Seattle, WA, United States of America

Rhea N Coler

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Rhea N. Coler: Pioneering Innovations in Tuberculosis Treatments

Introduction

Rhea N. Coler, based in Seattle, Washington, is a prominent inventor with a total of 11 patents to her name. She has made significant contributions in the field of immunology, particularly focusing on the treatment and prevention of tuberculosis infections. Her groundbreaking work has the potential to change the landscape of infectious disease management.

Latest Patents

Among Rhea's latest patents are:

1. **Immunogenic Compositions Comprising Polypeptides and Fusions Thereof** - This invention relates to compositions and fusion proteins containing at least two antigens, along with polynucleotides encoding such compositions and fusion proteins. It also encompasses methods for using these innovations in the treatment, prevention, and/or diagnosis of tuberculosis.

2. **Compositions and Methods for Treating an Active Infection** - This patent outlines methods and compositions aimed at treating an active tuberculosis infection. It further details strategies for enhancing the efficacy of chemotherapy regimens against such infections, including those resulting from the reactivation of latent infections.

Career Highlights

Rhea has worked with several reputable organizations throughout her career, including the Infectious Disease Research Institute and Corixa Corporation. Her roles at these institutions have allowed her to explore and develop new therapeutic approaches to combat infectious diseases, particularly tuberculosis.

Collaborations

Throughout her career, Rhea has collaborated with notable experts in her field, including Steven G. Reed and Gregory C. Ireton. These partnerships have been vital in advancing research and developing innovative solutions in the fight against tuberculosis.

Conclusion

Rhea N. Coler stands out as a leader in the field of infectious disease research, with her innovative patents addressing critical medical challenges. Her ongoing commitment to developing effective treatments for tuberculosis highlights her role as a significant contributor to medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…